Exploring the Feasibility of Comprehensive Uncertainty Assessment in Health Economic Modeling: A Case Study

Svenja Petersohn, Sabine E. Grimm*, Bram L. T. Ramaekers, Arina J. ten Cate-Hoek, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)

Abstract

Objectives: Decision makers adopt health technologies based on health economic models that are subject to uncertainty. In an ideal world, these models parameterize all uncertainties and reflect them in the cost-effectiveness probability and risk associated with the adoption. In practice, uncertainty assessment is often incomplete, potentially leading to suboptimal reimbursement recommendations and risk management. This study examines the feasibility of comprehensive uncertainty assessment in health economic models.

Methods: A state transition model on peripheral arterial disease treatment was used as a case study. Uncertainties were identified and added to the probabilistic sensitivity analysis if possible. Parameter distributions were obtained by expert elicitation, and structural uncertainties were either parameterized or explored in scenario analyses, which were model averaged.

Results: A truly comprehensive uncertainty assessment, parameterizing all uncertainty, could not be achieved. Expert elicitation informed 8 effectiveness, utility, and cost parameters. Uncertainties were parameterized or explored in scenario analyses and with model averaging. Barriers included time and resource constraints, also of clinical experts, and lacking guidance regarding some aspects of expert elicitation, evidence aggregation, and handling of structural uncertainty. The team's multidisciplinary expertise and existing literature and tools were facilitators.

Conclusions: While comprehensive uncertainty assessment may not be attainable, improvements in uncertainty assessment in general are no doubt desirable. This requires the development of detailed guidance and hands-on tutorials for methods of uncertainty assessment, in particular aspects of expert elicitation, evidence aggregation, and handling of structural uncertainty. The issue of benefits of uncertainty assessment versus time and resources needed remains unclear.

Original languageEnglish
Pages (from-to)983-994
Number of pages12
JournalValue in Health
Volume24
Issue number7
DOIs
Publication statusPublished - Jul 2021

Keywords

  • uncertainty analysis
  • DECISION-ANALYTIC MODELS
  • COST-EFFECTIVENESS
  • STRUCTURAL UNCERTAINTY
  • EXPECTED VALUE
  • INFORMATION
  • ASPIRIN
  • GUIDELINES
  • PERFECT
  • EVENTS
  • SAMPLE

Cite this